Tower Research Capital (TRC)’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.63K | Sell |
|
|||||
|
2025
Q1 | $6.79K | Buy |
|
|||||
|
2024
Q4 | $4.64K | Sell |
|
|||||
|
2024
Q3 | $4.15K | Sell |
|
|||||
|
2024
Q2 | $6.67K | Buy |
|
|||||
|
2024
Q1 | $3.81K | Buy |
|
|||||
|
2023
Q4 | $1.84K | Buy |
|
|||||
|
2023
Q3 | $1.09K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $0 | Sell |
|
|||||
|
2022
Q4 | $4K | Sell |
|
|||||
|
2022
Q3 | $6K | Buy |
|
|||||
|
2022
Q2 | $5K | Buy |
|
|||||
|
2022
Q1 | $5K | Sell |
|
|||||
|
2021
Q4 | $8K | Buy |
|
|||||
|
2021
Q3 | $7K | Buy |
|
|||||
|
2021
Q2 | $14K | Sell |
|
|||||
|
2021
Q1 | $29K | Sell |
|
|||||
|
2020
Q4 | $53K | Sell |
|
|||||
|
2020
Q3 | $196K | Buy |
|
|||||
|
2020
Q2 | $26K | Buy |
|
|||||
|
2020
Q1 | $22K | Buy |
|
|||||
|
2019
Q4 | $1K | Sell |
|
|||||
|
2019
Q3 | $23K | Buy |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $21K | Sell |
|
|||||
|
2018
Q4 | $44K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $8K | Buy |
|